Tilaknagar Industries , a prominent player in the Indian spirits industry, has unveiled ambitious financial projections during a recent conference call, signaling strong growth expectations for the coming years.

Growth Projections

The company outlined its vision for the future, expecting:

• Mid-teens volume growth for FY26 standalone business (excluding Imperial Blue)
• EBITDA margins around 60% for FY27-28

These projections reflect the company's confidence in its business strategy and market position.

Imperial Blue Deal Impact

Tilaknagar Industries plans to provide revised guidance for the combined business after the closure of the Imperial Blue deal. This strategic move is expected to significantly impact the company's future performance.

Revenue Growth Outlook

For FY26, the company anticipates that revenue growth will be slightly below volume growth. This projection is attributed to a higher Net Sales Realization (NSR) base in the first half of FY25.

Investor Communication

Tilaknagar Industries continues to maintain transparent communication with its stakeholders. The company recently announced:

• An upcoming interaction with analysts and investors on November 19, 2025, at the Avendus Spark INDX Annual Investor Conference in Mumbai.
• The availability of an audio recording from their Q2 H1 FY26 results conference call on the company's website.

These initiatives demonstrate Tilaknagar Industries' commitment to keeping investors informed about its performance and future strategies.

As the company moves forward with its growth plans and the integration of the Imperial Blue business, market observers will be watching closely to see how these projections materialize and impact Tilaknagar Industries' position in the competitive Indian spirits market.

Tilaknagar Industries , a leading Indian Made Foreign Liquor (IMFL) manufacturer, has released its financial results for the second quarter, showcasing strong growth and strategic initiatives.

Financial Performance

The company reported a 6.2% year-on-year increase in net revenue, reaching ₹398.00 crore for Q2. This growth was primarily driven by a robust 16.2% increase in sales volume, with the company selling 34.20 lakh cases during the quarter.

EBITDA and Market Share

Tilaknagar Industries reported an EBITDA of ₹60.00 crore for Q2. The company also highlighted strong market share gains across key markets, reflecting its brand performance and strategic initiatives.

Board Appointments and ESOP Scheme

In addition to the financial results, Tilaknagar Industries made several important announcements:

1. The company appointed Mr. Jenamejayana Kamalam Shivan as an Additional Independent Director for a term of 3 years.
2. Tilaknagar Industries launched the Employee Stock Option Scheme 2025, offering 50,00,000 stock options to eligible employees.

Financial Highlights

Conclusion

Tilaknagar Industries has demonstrated strong volume growth and market share gains in Q2. The company's strategic moves, including the appointment of a new director and the launch of an employee stock option scheme, suggest a focus on strengthening governance and employee alignment with company goals. As the company continues to expand its market presence, investors and analysts will likely keep a close eye on how these initiatives translate into sustained financial performance in the coming quarters.